- Luncheon Seminar
[LS-01] Medical Division, Novartis Pharma K.K.
It is time to think about the benefit-risk balance of fingolimod from the perspectives in case reports
Wed. May 23, 2018 12:05 PM - 1:05 PM Room 5 (Sapporo Geibunkan / Seiryu (3F))
Chair: Takashi Yamamura(Director and Chief of the Neuroimmunology Section, Director of Multiple Sclerosis Center, the Department of Immunology, National Institute of Neuroscience,
National Center of Neurology and Psychiatry)